Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03922204
Title A Study of Bispecific Antibody MCLA-145 in Patients With Advanced or Metastatic Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Merus N.V.
Indications

B-cell lymphoma

Advanced Solid Tumor

Therapies

MCLA-145

Age Groups: adult | senior
Covered Countries USA | ESP | BEL


No variant requirements are available.